Stage-dependent doxorubicin toxicity impairs C2C12 myogenesis via AMPK/AKT-FOXO signaling and is attenuated by metformin.
- DOI
- 10.1016/j.etap.2026.105147
- Published
- 2026 Aug 26
- Container
- Environmental toxicology and pharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.etap.2026.105147,
title = {Stage-dependent doxorubicin toxicity impairs C2C12 myogenesis via AMPK/AKT-FOXO signaling and is attenuated by metformin.},
author = {Kim SH and Ryu CS and Yun C and Woo R and Kim SK and Jung YS},
year = {2026},
journal = {Environmental toxicology and pharmacology},
doi = {10.1016/j.etap.2026.105147},
url = {https://doi.org/10.1016/j.etap.2026.105147}
}RIS
TY - JOUR TI - Stage-dependent doxorubicin toxicity impairs C2C12 myogenesis via AMPK/AKT-FOXO signaling and is attenuated by metformin. AU - Kim SH AU - Ryu CS AU - Yun C AU - Woo R AU - Kim SK AU - Jung YS PY - 2026 JO - Environmental toxicology and pharmacology DO - 10.1016/j.etap.2026.105147 UR - https://doi.org/10.1016/j.etap.2026.105147 ER -
APA
SH, K., CS, R., C, Y., R, W., SK, K., & YS, J. (2026). Stage-dependent doxorubicin toxicity impairs C2C12 myogenesis via AMPK/AKT-FOXO signaling and is attenuated by metformin.. Environmental toxicology and pharmacology. https://doi.org/10.1016/j.etap.2026.105147
Source records
- pubmed · retrieved 2026-09-25T22:39:39.522Z